New Zealand markets closed

Qiagen N.V. (QGEN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
41.86-0.03 (-0.07%)
At close: 04:00PM EDT
41.38 -0.50 (-1.19%)
After hours: 04:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close41.89
Bid40.95 x 1000
Ask42.70 x 800
Day's range41.01 - 41.90
52-week range34.74 - 47.70
Avg. volume1,065,138
Market cap9.287B
Beta (5Y monthly)0.42
PE ratio (TTM)27.54
EPS (TTM)1.52
Earnings date06 Aug 2024 - 12 Aug 2024
Forward dividend & yield1.28 (2.94%)
Ex-dividend date30 Jan 2024
1y target est50.24
  • Zacks

    QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions

    QIAGEN's (QGEN) latest QCI Interpret release improves the performance of high-throughput NGS labs.

  • Zacks

    QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays

    QIAGEN (QGEN) launches new QIAcuity dPCR assays for microbial applications, enhancing infectious disease research and surveillance.

  • GlobeNewswire

    QIAGEN announces 2028 strategy for solid profitable growth

    Hosts Capital Markets Day event in New York to outline strategy anchored by sharpened focus on growth pillars set to drive about 7% CER sales CAGR from 2024-2028 // Targeting at least 31% CER adjusted operating income margin in 2028 from portfolio streamlining (including NeuMoDx decision), operational efficiency gains and digitization // Ensuring disciplined capital allocation with high level of R&D and digital investments, focus on value-creating M&A opportunities and plans to return at least $